Oncolytic Adenovirus Expressing IL-23 and p35 Elicits IFN-gamma- and TNF-a-Co-Producing T Cell-Mediated Antitumor Immunity
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Il-Kyu | - |
dc.contributor.author | Li, Yan | - |
dc.contributor.author | Oh, Eonju | - |
dc.contributor.author | Yun, Chae-Ok | - |
dc.date.accessioned | 2021-08-03T12:49:35Z | - |
dc.date.available | 2021-08-03T12:49:35Z | - |
dc.date.created | 2021-07-26 | - |
dc.date.issued | 2013-05 | - |
dc.identifier.issn | 1525-0016 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/48398 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.title | Oncolytic Adenovirus Expressing IL-23 and p35 Elicits IFN-gamma- and TNF-a-Co-Producing T Cell-Mediated Antitumor Immunity | - |
dc.type | Conference | - |
dc.contributor.affiliatedAuthor | Yun, Chae-Ok | - |
dc.identifier.scopusid | 2-s2.0-84879763281 | - |
dc.identifier.wosid | 000319858400130 | - |
dc.identifier.bibliographicCitation | 16th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), pp.S53 | - |
dc.relation.isPartOf | 16th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT) | - |
dc.relation.isPartOf | MOLECULAR THERAPY | - |
dc.citation.title | 16th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT) | - |
dc.citation.startPage | S53 | - |
dc.citation.endPage | S53 | - |
dc.citation.conferencePlace | US | - |
dc.citation.conferencePlace | Salt Lake City, UT | - |
dc.citation.conferenceDate | 2013-05-15 | - |
dc.type.rims | CONF | - |
dc.description.journalClass | 1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.